wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38688235-4373008E-36E4-4287-9619-2430E0B23623
Q38688235-4373008E-36E4-4287-9619-2430E0B23623
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38688235-4373008E-36E4-4287-9619-2430E0B23623
Molecular basis of high viscosity in concentrated antibody solutions: Strategies for high concentration drug product development
P2860
Q38688235-4373008E-36E4-4287-9619-2430E0B23623
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38688235-4373008E-36E4-4287-9619-2430E0B23623
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a20c9c1ebd30d79a4407d2721a9206106137bad3
P2860
A randomized multi-center phase II trial of the angiogenesis inhibitor Cilengitide (EMD 121974) and gemcitabine compared with gemcitabine alone in advanced unresectable pancreatic cancer.